Thomas C Spelsberg from 509 Westmorland Blvd, Madison, WI 53711, age 49, Phone: 608 661-9874

Resumes

Vice President - Business Unit Services

view source

Location:

1214 Redan Dr, Verona, WI 53593

Industry:

Insurance

Work:

Wps Health Solutions
Vice President - Business Unit Services
Cuna Mutual Group Apr 2015 - Dec 2016
Director, Pmo
Cuna Mutual Group Jul 2012 - Apr 2015
Senior It Manager - Consumer Program Delivery
Mattel, Inc. Dec 2009 - Jul 2012
Senior Manager - Multi-Channel It
Mattel, Inc. 2005 - Nov 2009
It Project Manager and Business Analyst

Education:

Wisconsin School of Business 2000 - 2003
Master of Business Administration, Masters James A. Graaskamp Center For Real Estate 2000 - 2003
Master of Business Administration, Masters University of Wisconsin - Madison 1994 - 1998
Bachelors, Marketing, Psychology

Skills:

Business Analysis
Cross Functional Team Leadership
Project Management
Management
E Commerce
Leadership
Vendor Management
Project Portfolio Management
Process Improvement
Crm
Strategy
Team Management
Business Process Improvement
Strategic Planning
It Strategy
Integration
Training
Sdlc
Pmo
Software Project Management
Analytics
Resource Management
Information Technology
It Management
Program Management
Requirements Analysis
Team Leadership
Testing
Enterprise Software
Product Management
Business Strategy
Project Planning
Change Management
Business Intelligence
Business Development
Pmp
Multi Channel Marketing
Erp
Cms
Project Delivery
People Management
Business Case Preparation
Project Finance
Project Implementation
Project Coordination
Project Execution
E Commerce Solutions
Process Development
Content Management
Social

Certifications:

Professional Scrum Master I

Distinguished Investigator At Mayo Clinic

view source

Location:

Rochester, Minnesota Area

Industry:

Research

Us Patents

Transgenic Tieg Non-Human Animals
view source
US Patent:

7304203, Dec 4, 2007
Filed:

Sep 17, 2004
Appl. No.:

10/944454
Inventors:

Thomas C. Spelsberg - Rochester MN, US
Malayannan Subramaniam - Zumbrota MN, US
Merry Jo Velasquez - Cannon Falls MN, US
Nalini M. Rajamannan - Chicago IL, US
Assignee:

Mayo Foundation for Medical Education and Research - Rochester MN
International Classification:

A01K 67/033
A01K 67/027
A01K 67/00
US Classification:

800 18, 800 13, 800 14
Abstract:

Materials and methods related to a transgenic non-human animal (e. g. , a transgenic non-human mammal) whose genome comprises a disrupted TIEG allele are provided. Methods for making such transgenic non-human animals, and using them to identify and characterize agents that affect conditions related to TIEG activity, such as cardiac hypertrophy and bone formation also are provided. In addition, materials and methods related to the treatment of hypertrophic cardiomyopathy are provided.

Determining Cancer Aggressiveness
view source
US Patent:

20030198961, Oct 23, 2003
Filed:

Apr 15, 2002
Appl. No.:

10/123626
Inventors:

Thomas Spelsberg - Rochester MN, US
Patrick Roche - Rochester MN, US
Monica Reinholz - Rochester MN, US
Steven Johnsen - Rochester MN, US
Malayannan Subramaniam - Zumbrota MN, US
International Classification:

C12Q001/68
G01N033/574
C07H021/04
C12P019/34
C07K016/40
US Classification:

435/006000, 435/007230, 435/091200, 530/388260, 536/024300
Abstract:

The invention provides materials and methods for determining the aggressiveness of a cancer in a mammal. Specifically, the invention provides methods and methods for measuring the level of a TIEG marker in a sample. Such levels can be correlated with the aggressiveness of a cancer to predict patient outcome and develop treatment regimens.

Transgenic Tieg Non-Human Animals
view source
US Patent:

20080300184, Dec 4, 2008
Filed:

Oct 5, 2007
Appl. No.:

11/868324
Inventors:

Thomas C. Spelsberg - Rochester MN, US
Malayannan Subramaniam - Zumbrota MN, US
Merry Jo Velasquez - Cannon Falls MN, US
Nalini M. Rajamannan - Chicago IL, US
International Classification:

A61K 38/18
A61K 31/7105
A61K 31/565
US Classification:

514 12, 514 44, 514182
Abstract:

Materials and Methods related to a transgenic non-human animal (e.g., a transgenic non-human mammal) whose genome comprises a disrupted TIEG allele are provided. Methods for making such transgenic non-human animals, and using them to identify and characterize agents that affect conditions related to TIEG activity, such as cardiac hypertrophy and bone formation also are provided. In addition, materials and methods related to the treatment of hypertrophic cardiomyopathy are provided.

Dna Encoding Tgf-.Beta. Inducible Early Factor-1 (Tief-1), A Gene Expressed By Osteoblasts
view source
US Patent:

59812176, Nov 9, 1999
Filed:

Dec 11, 1995
Appl. No.:

8/570227
Inventors:

Malayannan Subramaniam - Zumbrota MN
Thomas C. Spelsberg - Rochester MN
Assignee:

Mayo Foundation for Medical Education and Research - Rochester MN
International Classification:

C12P 2106
C12N 120
C12N 1500
C07H 2104
US Classification:

435 691
Abstract:

An isolated and purified DNA molecule encoding TGF-. beta. inducible early factor-1 (TIEF-1) is provided. A method of isolating a growth factor- or differentiation factor-inducible gene is also provided.

Nuclear Binding Assay For Steroid Receptor Functionality In Cancerous Cells
view source
US Patent:

48064645, Feb 21, 1989
Filed:

Feb 11, 1987
Appl. No.:

7/013569
Inventors:

Thomas C. Spelsberg - Rochester MN
Assignee:

Mayo Foundation for Medical Education and Research - Rochester MN
International Classification:

C12Q 168
C12Q 120
G01N 33566
G01N 33567
US Classification:

435 6
Abstract:

A method for rapidly determining the presence of functional cellular steroid receptors by assaying a tissue sample for nuclear steroid or antisteroid binding is disclosed which comprises treating the tissue with collagenase, incubating the isolated cells with a labelled steroid or a labelled antisteroid capable of complexing said receptors and measuring the bound nuclear radioactivity and the DNA of the isolated cellular nuclei.

Immortalized Human Fetal Osteoblastic Cells
view source
US Patent:

56911750, Nov 25, 1997
Filed:

Jul 12, 1993
Appl. No.:

8/089848
Inventors:

Steven A. Harris - Rochester MN
Thomas C. Spelsberg - Rochester MN
Assignee:

Mayo Foundation for Medical Education and Research - Rochester MN
International Classification:

C12N 1564
C12N 510
US Classification:

4351723
Abstract:

Immortalized normal human fetal osteoblastic cells that express a temperature sensitive mutant of simian virus 40 large T antigen are provided.

Method And Kit To Assay For Steroid Receptor Functionality In Cancerous Cells
view source
US Patent:

50304178, Jul 9, 1991
Filed:

Nov 3, 1989
Appl. No.:

7/431695
Inventors:

Thomas C. Spelsberg - Rochester MN
Assignee:

Mayo Foundation for Medical Education and Research - Rochester MN
International Classification:

G01N 33574
US Classification:

422 61
Abstract:

A method and a test kit for rapidly determining the presence of functional cellular steroid receptors by assaying a tissue sample for nuclear steroid or antisteroid binding is disclosed which comprises treating the tissue with collagenase, incubating the isolated cells with a labelled steroid or a labelled antisteroid capable of complexing said receptors and measuring the bound nuclear radioactivity and the DNA of the isolated cellular nuclei.

Immortalized Human Fetal Osteoblastic Cells
view source
US Patent:

56817010, Oct 28, 1997
Filed:

Jul 11, 1994
Appl. No.:

8/273351
Inventors:

Steven A. Harris - Rochester MN
Thomas C. Spelsberg - Rochester MN
Assignee:

Mayo Foundation for Medical Education and Research - Rochester MN
International Classification:

C12Q 168
US Classification:

435 6
Abstract:

Immortalized normal human fetal osteoblastic cells that express a temperature sensitive mutant of simian virus 40 large T antigen are provided.